🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess if PD-L1 expression can be upregulated in peritoneal metastases f...
Status
Recruiting
Location
University of Chicago
Start Date
2025-09-09
Trial ID
NCT04107077
This study was conducted to evaluate the preliminary effectiveness and safe...
Status
Completed
Location
The First Affiliated Hospital of Wannan Medical College
Start Date
2023-03-08
Trial ID
NCT05577702
Treatments Being Tested
This is an open label, dose-seeking phase 1/2 study using escalating doses ...
Status
Recruiting
Location
Sarcoma Oncology Research Center
Start Date
2017-04-13
Trial ID
NCT03138161
Treatments Being Tested
Chordomas are very rare malignant tumors, chemo-resistant with high propens...
Status
Completed
Location
CHU de Saint-Etienne
Start Date
2020-04-01
Trial ID
NCT04486820
Treatments Being Tested
The detection of tissue PD-L1 immunohistochemistry in NSCLC has an importan...
Status
Completed
Location
the second affiliated hospital of Army medical university
Start Date
2017-07-01
Trial ID
NCT02869685
Treatments Being Tested
Background: Programmed cell death protein 1 (PD-L1) is a protein on the su...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2018-12-19
Trial ID
NCT03707587
Treatments Being Tested
This study is researching an experimental drug called fianlimab (also calle...
Status
Recruiting
Location
University of California Los Angeles
Start Date
2026-04-14
Trial ID
NCT06769698
Treatments Being Tested
This is a feasibility study for the use of \[18F\]PD-L1 as a PET tracer tha...
Status
Completed
Location
UMCG
Start Date
2017-05-22
Trial ID
NCT03520634
Treatments Being Tested
Pembrolizumab is a potent and highly selective humanized monoclonal antibod...
Status
Unknown
Location
Medical University of Vienna
Start Date
2020-02-10
Trial ID
NCT03571360
Treatments Being Tested
The purpose of this study is to determine if neoadjuvant (treatment before ...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2024-05-17
Trial ID
NCT06295159
Treatments Being Tested